National ReviewRight·
The FDA’s Proposed Drug Ad Rule Is a Blueprint for Violating the First Amendment
Interestingly, FDA’s impending rule has attracted support from the far left.
Read at National Review →
Opinion · 1 sources covering this
The FDA’s Proposed Drug Ad Rule Is a Blueprint for Violating the First Amendment
Interestingly, FDA’s impending rule has attracted support from the far left.
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/80665c1c384de832d129fe76db789f5649ab6aa3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="The FDA’s Proposed Drug Ad Rule Is a Blueprint for Violating the First Amendment"></iframe>
